Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Evofem Biosciences Inc (NQ: EVFM )

2.290 USD +0.030 (+1.33%)
Official Closing Price Updated: 4:31 PM EST, Nov 27, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,187,000
Open 2.270
Bid (Size) 2.270 (2)
Ask (Size) 2.300 (14)
Prev. Close 2.260
Today's Range 2.150 - 2.295
52wk Range 1.910 - 7.500
Shares Outstanding 17,763,340
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Evofem Biosciences to Participate in Piper Sandler 32nd Annual Virtual Healthcare Conference
Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced it will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference, taking place virtually November 30 through December 3,... 
From PR Newswire
Evofem Biosciences to Present at Stifel Virtual Healthcare Conference
Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced it will present at the Stifel Virtual Healthcare Conference on Wednesday November 18, 2020 at 4:00 p.m. ET. 
From PR Newswire

Performance

YTD
-61.05%
-61.05%
1 Month
-8.03%
-8.03%
3 Month
-31.02%
-31.02%
6 Month
-54.74%
-54.74%
1 Year
-62.52%
-62.52%

More News

Read More
Evofem Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Update
From PR Newswire
Does Your List Of Penny Stocks Have These 4 Biotech Names On It?
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Evofem Biosciences to Report Third Quarter 2020 Results and Provide Corporate Update on Monday, November 9, 2020
From PR Newswire
Evofem Biosciences to Participate in Virtual Investor KOL Roundtable
From PR Newswire
JTC Team to Host Virtual Investor KOL Roundtable on October 27th, 28th and 29th
From ACCESSWIRE
Graphic Design Magazine Recognizes ProAmpac & Evofem Biosciences® with 2020 HEALTH+WELLNESS Award
From Business Wire News Releases
Evofem Biosciences Announces First Patient Enrolled in Pivotal Phase 3 Trial of EVO100 for Prevention of Chlamydia and Gonorrhea
From PR Newswire
Evofem Biosciences Secures $25 Million Strategic Investment from Adjuvant Capital
From PR Newswire
Evofem Biosciences Announces Presentations on Phexxi and EVO100 at Key Medical Society Meetings
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]